AI is improving idiopathic pulmonary fibrosis care
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease characterised by the accumulation of scar tissue in the lungs, leading…
Analyst Comment
Infectious disease screening during substance use disorder treatment increases detection, prevention, and treatment
US eosinophilic oesophagitis market to reach $1.19bn by 2030
Lilly first to opt for confidential reimbursement price in Germany
New US-EU trade deal on tariffs ends pharma’s geopolitical immunity
South Korea emerges as 2025 licensing hub with 113% growth and billion-dollar deals
HS market forecast to reach $7.8bn across 7MM by 2034
Pharma braces for critical French drug pricing reforms pending CEPS’s report
